David J Rawson,
Delphine Brugier,
Anthony Harrison, Jo Hough,
Julie Newman,
Joe Otterburn,
Graham N Maw,
Jenny Price,
Lisa R Thompson,
Paul Turnpenny,
Andrew N Warren
[show abstract]
[hide abstract]
ABSTRACT: Conformational constraint has been used to design a potent series of α(2)δ ligands derived from the readily available starting material (2S,4R)-hydroxy-l-proline. The ligands have improved physicochemistry and potency compared to their linear counterparts (described in our earlier publication) and the lead compound has been progressed to clinical development.
Bioorganic & medicinal chemistry letters 06/2011; 21(12):3767-70. · 2.65 Impact Factor